UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

The nexus of opioids, pain, and addiction: Challenges and solutions

Preventive medicine, 2019-11, Vol.128, p.105852-105852, Article 105852

2019

Volltextzugriff (PDF)

REL-1017 (esmethadone; d-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley rats

Scientific reports, 2022-07, Vol.12 (1), p.11389-11389, Article 11389

2022

Volltextzugriff (PDF)

Integration of genomic and clinical data augments surveillance of healthcare-acquired infections

Infection control and hospital epidemiology, 2019-06, Vol.40 (6), p.649-655

2019

Volltextzugriff (PDF)

Accuracy of Infection Control Surveillance in Identifying Genomically Confirmed Cross Transmission Clusters

Infection control and hospital epidemiology, 2020-10, Vol.41 (S1), p.s439-s440

2020

Volltextzugriff (PDF)

A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers

Addiction (Abingdon, England), 2013-06, Vol.108 (6), p.1095-1106

2013

Volltextzugriff (PDF)

Assessment of a formulation designed to be crush-resistant in prescription opioid abusers

Drug and alcohol dependence, 2012-11, Vol.126 (1), p.206-215

2012

Volltextzugriff (PDF)

Precision Infection Prevention (PIP) as a New Standard of Practice Within Longitudinal Infection Prevention and Surveillance

Infection control and hospital epidemiology, 2020-10, Vol.41 (S1), p.s449-s450

2020

Volltextzugriff (PDF)

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users

Translational psychiatry, 2023-06, Vol.13 (1), p.192-12, Article 192

2023

Volltextzugriff (PDF)

Prescription Opioid Abuse, Prescription Opioid Addiction, and Heroin Abuse Among Adolescents in a Recovery High School: A Pilot Study

Journal of child & adolescent substance abuse, 2016-03, Vol.25 (2), p.105-112

2016

Volltextzugriff (PDF)

A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market

Drug and alcohol dependence, 2024-07, Vol.260, p.110414, Article 110414

2024

Volltextzugriff (PDF)

M134 - A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market

Drug and alcohol dependence, 2024-07, Vol.260

2024

Volltextzugriff (PDF)

Psychedelic Drug Abuse Potential Assessment Challenges to Scientific Validity and Real World Predictiveness: Current Approaches and Research Gaps

Drug and alcohol dependence, 2024-07, Vol.260, p.110269, Article 110269

2024

Volltextzugriff (PDF)

S158 - Psychedelic Drug Abuse Potential Assessment Challenges to Scientific Validity and Real World Predictiveness: Current Approaches and Research Gaps

Drug and alcohol dependence, 2024-07, Vol.260

2024

Volltextzugriff (PDF)

Relationship between rate of infusion and reinforcing strength of oxycodone in humans

Journal of opioid management, 2009-07, Vol.5 (4), p.203

2009

Volltextzugriff (PDF)

Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications

Drug and alcohol dependence, 2024-07, Vol.260, p.110862, Article 110862

2024

Volltextzugriff (PDF)

W161 - Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications

Drug and alcohol dependence, 2024-07, Vol.260

2024

Volltextzugriff (PDF)

The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act

Psychopharmacology, 2023-04, Vol.240 (4), p.699-711

2023

Volltextzugriff (PDF)

Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective

Journal of psychopharmacology (Oxford), 2023-01, Vol.37 (1), p.33-44

2023

Volltextzugriff (PDF)

Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

Advances in therapy, 2010-06, Vol.27 (6), p.381-399

2010

Volltextzugriff (PDF)

A comparison among tapentadol tamper‐resistant formulations ( TRF ) and O xy C ontin ® (non‐ TRF ) in prescription opioid abusers

Addiction (Abingdon, England), 2013-06, Vol.108 (6), p.1095-1106

2013

Volltextzugriff (PDF)

531. Practical and Evidence-Based Considerations for Implementation of Bacterial Whole-Genome Sequencing Within Longitudinal Infection Control Practice

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S255-S255

2019

Volltextzugriff (PDF)

Utility of Antinuclear Antibody Screening by Various Methods in a Clinical Laboratory Patient Cohort

The journal of applied laboratory medicine, 2016-07, Vol.1 (1), p.36-46

2016

Volltextzugriff (PDF)

Erratum to: Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

Advances in therapy, 2010-12, Vol.27 (12), p.981-981

2010

Volltextzugriff (PDF)

Functional Profiles of Healthy Older Persons

Age and ageing, 1994-01, Vol.23 (1), p.34-39

1994

Volltextzugriff (PDF)

Funny face

Seventeen, 1981-05, Vol.40 (5), p.108

Ashworth, Judy

1981

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(13)
Humans
(8)
Adult
(6)
Drug Abuse
(6)
Female
(6)
Male
(6)
Middle Aged
(5)
Psychiatry
(5)
Abuse Deterrent
(4)
Biological And Medical Sciences
(4)
Psychology. Psychoanalysis. Psychiatry
(4)
Surveillance
(4)
Aged
(3)
Analgesics, Opioid - Administration & Dosage
(3)
Disease Control
(3)
Drug Addiction
(3)
Epidemiology
(3)
Medical Sciences
(3)
Medicine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The nexus of opioids, pain, and addiction: Challenges and solutions

REL-1017 (esmethadone; d-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley rats

Integration of genomic and clinical data augments surveillance of healthcare-acquired infections

Accuracy of Infection Control Surveillance in Identifying Genomically Confirmed Cross Transmission Clusters

A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers

Assessment of a formulation designed to be crush-resistant in prescription opioid abusers

Precision Infection Prevention (PIP) as a New Standard of Practice Within Longitudinal Infection Prevention and Surveillance

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users

Prescription Opioid Abuse, Prescription Opioid Addiction, and Heroin Abuse Among Adolescents in a Recovery High School: A Pilot Study

A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market

M134 - A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market

Psychedelic Drug Abuse Potential Assessment Challenges to Scientific Validity and Real World Predictiveness: Current Approaches and Research Gaps

S158 - Psychedelic Drug Abuse Potential Assessment Challenges to Scientific Validity and Real World Predictiveness: Current Approaches and Research Gaps

Relationship between rate of infusion and reinforcing strength of oxycodone in humans

Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications

W161 - Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications

The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act

Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective

Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

A comparison among tapentadol tamper‐resistant formulations ( TRF ) and O xy C ontin ® (non‐ TRF ) in prescription opioid abusers

531. Practical and Evidence-Based Considerations for Implementation of Bacterial Whole-Genome Sequencing Within Longitudinal Infection Control Practice

Utility of Antinuclear Antibody Screening by Various Methods in a Clinical Laboratory Patient Cohort

Erratum to: Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

Functional Profiles of Healthy Older Persons

Funny face

Suchergebnisse filtern